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Abstract
Hepatitis E, which is caused by hepatitis E virus (HEV), may now be considered a zoonosis as well as an anthroponosis. Pigs, boars and
deer have been identiﬁed as reservoirs, and their ﬂesh and entrails—as meat and offal—as vehicles of HEV transmission. Shellﬁsh also
act as vehicles. Dietary, gastronomic and culinary preferences inﬂuence how extensively HEV conveyed by these vehicles can be inacti-
vated before their ingestion by the host. Another route of infection is paved by HEV that is enterically shed by humans and by live
animals into the environment. Although anthroponotic transmission of HEV is primarily environmental, zoonotic transmission may
proceed along both foodborne and environmental routes.
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Introduction
Percy Shelley’s magniﬁcent poem Queen Mab includes these
poignant lines: ‘‘No longer now/He slays the lamb that looks
him in the face.’’ Commenting on them, Shelley wrote:
‘Comparative anatomy teaches us that man resembles
frugivorous animals in everything, and carnivorous in
nothing; he has neither claws wherewith to seize his
prey, nor distinct and pointed teeth to tear the living
ﬁbre … It is only by softening and disguising dead ﬂesh
by culinary preparation that it is rendered susceptible of
mastication or digestion; and that the sight of its bloody
juices and raw horror does not excite intolerable loath-
ing and disgust.’ [1]
The poet perhaps overlooked one more reason why meat
should be culinarily prepared: to inactivate pathogens that
might be lurking in it. Among such pathogens are hepatitis A
virus and hepatitis E virus (HEV), enterically transmitted
viruses that cause hepatitis [2].
HEV is the causative agent of hepatitis E. The epidemiol-
ogy of hepatitis E and HEV infection reﬂects the interplay
among several factors: viral transmissibility and virulence;
how conducive the environment is to HEV transmission; and
host susceptibility to infection and disease. Perceptions of
how HEV spreads, is transmitted to humans and causes
disease have changed radically. This review considers the
contribution of animals and their food products to infection
and disease.
Geographical Variations in the
Epidemiology of Human HEV Infection and
Disease
Hyperendemic regions
HEV is the foremost agent of waterborne jaundice outbreaks
[3]. In the 21st century, explosive outbreaks continue to
erupt in tropical and subtropical parts of the world. These
occurrences are triggered by faecal contamination of drinking
water. Contamination is, in turn, fostered by: the absence,
inadequacy or breakdown of sewage disposal or waste water
treatment systems; population displacement following armed
conﬂicts or natural catastrophes; ﬂooding; or a combination
of these. Between epidemics, rates of sporadic disease
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remain high. Regions may be referred to as being hyperen-
demic for HEV if an outbreak of hepatitis E has happened in
the past 40 years or HEV infection accounts for more than
25% of reported cases of sporadic acute non-A, non-B
hepatitis [4].
Whether epidemic or sporadic, hepatitis E tends to strike
adolescents and young adults of both sexes. Disease, when
manifest, often resolves spontaneously, but pregnant women
and people with underlying liver disease are at risk of devel-
oping and dying from fulminant hepatic failure [3,5]. Seropre-
valence data obtained from surveys conducted between
epidemics [6,7] show a steep rise in the anti-HEV-IgG detec-
tion rate from late childhood to early adulthood, with no
increase thereafter (Fig. 1a). In Egypt, some community sur-
veys have revealed an age-speciﬁc seroprevalence trend [8]
resembling that observed in South Asia, but others have
revealed early-childhood attainment of high seropositivity
rates, with no appreciable increase after late childhood [9]
(Fig. 1b). Immune responses evoked at an early age may be
associated with the overwhelmingly asymptomatic nature of
the infections observed [10,11]. In China, community sero-
surveys in southern and eastern provinces have shown a
steadily increasing trend in prevalence from childhood to old
age (Fig. 1c). This trend applies to both rural [12,13] and
urban [13] communities. Symptomatic disease is evident
[12,14–16], but few formal effect-measure assessments of
HEV infection (which would include morbidity and mortality)
[12] have been reported.
Endemic regions
Hepatitis E may also be encountered in temperate and rela-
tively afﬂuent regions of the world. Although disease can be
imported, it is increasingly diagnosed in people with no history
of recent travel abroad. In Japan alone, over 250 such cases
have been documented in the last decade [17]. Other coun-
tries where hepatitis E has become more apparent include
Taiwan, Korea, France, The Netherlands, Spain, Hungary,
Germany, the UK, Denmark, Norway and New Zealand
[18–28]. Countries that report non-imported, sporadic
hepatitis E may now be considered to be HEV-endemic [4].
Clinical attack rates tend to be higher in men than in
women, and in older (>50 years) than in younger people.
Pregnant women are rarely affected [29]. Disease is largely
self-limiting, but fulminant hepatitis and consequent death have
occasionally been observed, people with pre-existing liver
illness being at risk [17,30,31]. Occurrences of chronic hepati-
tis E in immunosuppressed people are being noted [32,33].
Community-based seroprevalence investigations conducted
in endemic countries have revealed a trend towards a steady
age-wise increase in the detection rate of anti-HEV-IgG
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FIG. 1. Geographical variation in age-speciﬁc prevalences of anti-hepatitis E virus IgG. Data from representative, large, community serosurveys
[6–9,12,13,34–37] are shown. Speciﬁc locality, period of study and sample size are indicated at top of each panel. In (b), the lower graph is
derived from [9] and the upper graph from [10]. As the performance characteristics of assays applied differ among studies, only interstudy
age-wise trends should be compared. Data from [37] have been adjusted for design parameters speciﬁc to the United States National Health
and Nutrition Examination Survey and to sample weights; data from other studies are crude.
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[34–37] (Fig. 1d). Deviations from this general trend are
probably due to cohort effects reﬂecting past perturba-
tions in the force of infection [36]. Testing for HEV RNA
in archived serum collections [38] provides valuable insights
into how the extent of incident HEV infection changes
over time.
Anthroponotic Transmission
Human-to-human HEV transmission per se appears to be
adequate to maintain HEV hyperendemicity. HEV is shed into
stools several days before the onset of jaundice or the rise
in activity of serum aminotransferases, until jaundice resolves
or liver function normalizes [39–41]. During this period, the
amount of virus excreted may be considerable: up to
108 HEV genome-copies per milligram of faeces [41]. People
who enterically shed virus in the acute phase of HEV infec-
tion, whether symptomatic or not [42], are likely to be
those contributing most to the reservoir pool. Lesser
contributors could be others who shed HEV in their faeces
protractedly following infection [43,44]. The viability of HEV
in water or sewage is unknown.
Intra-household, horizontal transmission of HEV is charac-
teristically infrequent [45] but the risks of HEV infection and
death in infants delivered from infected pregnant women are
high [3,46]. Infection following transfusion of blood or blood
products from HEV-viraemic donors has been documented
[47–49]. Parenteral transmission also possibly underlies the
occasional nosocomial outbreak of hepatitis E [50] and the
relatively high anti-HEV detection rates observed in haemo-
dialysis patients [51].
Zoonotic Transmission
Foodborne transmission
Porcine offal and meat. Yazaki et al. [52] investigated a series
of 29 cases of sporadic hepatitis E occurring in Hokkaido,
Japan, between 2001 and 2002, and identiﬁed nine patients
with a history of having recently ingested grilled pig liver. Pig
livers sold in grocery stores located in the patients’ neigh-
bourhoods were surveyed, which revealed that 2% of 363
packages sampled carried HEV RNA; one-third of the
sequences derived were near-identical or identical to HEV
sequences recovered from the case-patients. A subsequent
assessment of a larger series of patients with hepatitis E diag-
nosed in the island identiﬁed nearly 80% with a recent his-
tory of having eaten raw or undercooked pig liver, about half
of whom had consumed pig intestines [53].
In Virginia in the USA, 11% of 127 retail liver packages
tested were discovered to be positive for HEV RNA; speciﬁc
pathogen-free pigs inoculated with sample homogenates
became infected, implying relatively long-term survival of live
virus ex vivo under retail storage conditions [54]. Although
symptomatic HEV infection seems to be rare in the USA
[55], a 21% anti-HEV-IgG reactivity rate was found
among more than 18 000 serum samples collected in the
Third National Health and Nutrition Examination Survey
(III NHANES), and analysis of risk factors identiﬁed eating liver
or organ meat more than once per month to be associated
with increased odds of seroreactivity [37]. In The Nether-
lands, HEV genomic sequences generated from pig livers col-
lected from butchers [56] were observed to cluster closely
with those from indigenous human cases of hepatitis E
[57,58]. In Cornwall, UK, where indigenous hepatitis E has
been frequently observed [59], no HEV RNA was detected in
retail pig livers [60].
The potential of pork as a vehicle of HEV transmission
arises from one report describing a hepatitis E outbreak in a
Japanese family who shared a meal in which partially grilled
pork was served [49], and another of disease in a French cou-
ple who had eaten desiccated, uncooked pork [61]. The pau-
city of reports linking pork consumption with hepatitis E is
probably due to viraemia in pigs having cleared by the time of
their slaughter. Studies have consistently shown viraemia to
be most intense when pigs are between 1 and 3 months of
age, well before entry (at 5–6 months) into the ﬁnish phase
of production [18,62,63]. Moreover, there is little culinary
incentive to desist from cooking pork (particularly chops)
thoroughly, because, unlike liver or beef, unground pork in
the raw or undercooked state is not easily masticated.
The possibility of HEV transmission from contaminated
pigmeat incorporated in sausages has been raised [24,25].
However, sausages tend also to contain offal, which can orig-
inate from more than one species of livestock. A case–
control study reported from Germany did not ﬁnd exposure
to raw pigmeat and sausages—on account of their frequent
inclusion in the German diet—as being signiﬁcantly more
common among hepatitis E patients than among controls,
although it did identify the eating of offal as a risk [25].
Boar meat and offal. Data linking hepatitis E to consumption
of boar meat are appreciably more substantial than those for
pork [25,64–71]. In Japan, a number of cases and outbreaks
were found to be associated with the ingestion of insufﬁ-
ciently grilled meat [65,67,71]. One study determined that
the sequences of a relatively non-conserved segment of the
HEV genome ampliﬁed from the case-patient’s serum and
from a remnant of the implicated meat were identical [67].
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Other studies [65,68] linked disease to eating boar meat or
liver served raw—gastronomic offerings held in high regard
by some Japanese.
HEV transmission resulting from exposure to boar food
products also occurs in Europe. The German case–control
study [25] identiﬁed consumption of boar meat as a risk for
hepatitis E, independently of the ingestion of offal. The signif-
icance of that study arises not only from its design but also
from its use of a population-based control group.
Venison. Tei et al. [72] described HEV infection in two
Japanese families that shared several meals consisting of
raw venison from sika deer (Cervus nippon). That descrip-
tion is historically signiﬁcant, as it was the ﬁrst to provide
direct evidence that HEV can be transmitted zoonotically
along a foodborne route. A follow-up study showed that
the full-length sequence of the HEV genome derived from
one of the outbreak case patients was nearly identical
to that originating from a deer caught in the nearby
countryside [73]. A subsequent case–control study identi-
ﬁed the consumption of rare venison as a signiﬁcant risk
factor for anti-HEV-IgG seropositivity [74]. Few descrip-
tions of hepatitis E associated with such exposure have
ensued [68].
Animals as natural hosts of HEV and reservoirs for human
HEV infection
Pigs. Pigs have previously been recognized to play host to
HEV [75]. The extent of enzooticity is high, maintained by
the need to raise pigs under conﬁnement at high stocking
density to meet the demand for human consumption. Among
pigs bred in proximity, faecal–oral transmission perpetuates
HEV infection [78,79]. HEV RNA (including negative-stranded
RNA—signifying viral replication, as the HEV genome is posi-
tive-stranded) was detected in a variety of tissues and ﬂuids,
predominantly liver, mesenteric lymph nodes, the intestinal
tract and bile [76,77]. The animals remained asymptomatic
following infection, although there may have been some
degree of underlying hepatitis [80].
Whereas humans can be infected by any of the four geno-
types of HEV (designated 1–4), pigs are infected by geno-
types 3 and 4 only [81]. Swine HEV are potentially able to
infect humans, because they are transmissible to non-human
primates [75,82–84]. In India, humans with clinical hepatitis E
are infected by genotype 1 HEV, whereas pigs carry geno-
type 4 exclusively [85,86]. In Bangladesh, Pakistan and the
Kashmir, where huge epidemics caused by genotype 1 HEV
have occurred [3–5,7], pigs are not bred, nor do they mingle
with humans. Thus, in South Asia, there is no evidence of
swine-to-human HEV transmission.
By contrast, in the endemic countries, epidemiological link-
ages exist between swine and humans. HEV genotypes com-
mon to both species are as follows: 3 and 4 in Japan [81]; 4 in
Taiwan [87]; and 3 in Korea [88], Europe [18–27], the USA
[55] and New Zealand [28]. Signiﬁcantly, among genotypically
identical sequences that originate from the same country,
short evolutionary distances are often observed, regardless of
their human or porcine origin [49,52,54,56,57].
In China, a mixed epidemiological pattern is apparent,
reﬂecting a geographical variation or shift in the epidemiology
from HEV infection that is primarily associated with geno-
type 1 to one associated with genotype 4 [13–15]. Swine
serosurveys also reveal high rates of anti-HEV detection [89]
and faecal shedding [90]. Swine and human genotype 4 HEV
strains carried in their respective host species are very closely
related, consistent with cross-species spread [13,90,91]. The
modes of transmission remain uncharacterized.
Boars. Boars belong to the same species as pigs (Sus scrofa).
Wild boars are overabundant in Europe [92]. Serological
surveys conducted among boar populations in Japan [93–96]
and Europe [24,97,98] have revealed wide variations in sero-
positivity rates. A signiﬁcant proportion of boar HEV
sequences cluster with those from human hepatitis E cases
and pigs. This feature is shared with HEV sequences derived
from liver and faecal samples of wild boars in Hungary and
Germany [24,57,98,100]. The range of HEV RNA seroposi-
tivity rates seems to vary geographically; in Japan they were
found to vary from <1% to 2% [93,94,96], and in Europe
they were 5% [99], 25% [97] and 68% [98].
The differences in detection rates of HEV RNA thus far
reported need to be conﬁrmed using standardized assays, as
accurate data have a bearing on the making of correct infer-
ences concerning the burden of HEV infection among boars
and their potential for intraspecies and interspecies HEV trans-
mission. More precise assessments correlating the duration
and extent of HEV viraemia with age should also be consid-
ered. Finally, as boar hunting is a sport that is practised globally
[101,102], the transmissibility of HEV to its practitioners could
be examined more closely. Among boar hunters in Okinawa, a
signiﬁcantly higher anti-HEV seropositivity rate than in the
general population has been reported [137].
Deer. Surveys of wild sika deer caught across Japan have found
less than 3% of the sampled sera to be anti-HEV-IgG-reactive
[103,104], and none to be HEV RNA-positive [103]. In Mary-
land, USA, an investigation among sika deer in hunting sites
found that none of the samples tested carried anti-HEV-IgG
[105]. Although these marginal detection rates point to sika
deer as being accidental rather than natural hosts to HEV, the
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transmission link discovered between them and hepatitis E in
Japan [72–74] raised awareness of the potential that game ani-
mals have to spread HEV among themselves, to other animals
sharing the same habitat, and to humans who hunt and eat
them. In this regard, a report suggesting that the European
roe deer (Capreolus capreolus) in Hungary is a host to HEV
[24] and another suggesting that the caribou (Rangifer taran-
dus) in the Yukon is not [106] requires conﬁrmation.
Bovids. Seroprevalence studies of anti-HEV antibody in other
ungulates raised as livestock for food products—cattle, sheep
and goats—have given results ranging from complete absence
to low detection rates [24,86,91,107–111]. No positive HEV
RNA results have been obtained with their blood or bile
[112]. Accordingly, there is no ﬁrm evidence to implicate bo-
vids as hosts to HEV.
Non-foodborne, zoonotic transmission
Seroprevalence studies variously conducted among wild
rodents have yielded a wide range of reactivities [5,107–
111,113,114], and experimental studies undertaken to deter-
mine the susceptibility of rats and mice to HEV infection
have generated uncertain outcomes [115,116]. Studies on
other animals in the ﬁeld, including non-human primates,
horses, dogs, cats, rabbits, mongooses and other more exo-
tic animals, have yielded widely disparate data [107,117–125].
RT-PCRs for HEV RNA have given largely negative results.
Exceptions are ﬁndings of HEV RNA in the dung or blood of
several horses [121,123] and rabbits [124], and of a small
menagerie (including birds) enclosed in a wild-life preserve
[123]; these ﬁndings could reﬂect the animals’ status as
accidental rather than natural hosts.
Detection rates for anti-HEV-IgG tend to be higher in
people who work with swine, which includes veterinarians,
farmers and other farm workers [75,126–128], than in other
subpopulations. Frequent contact with HEV-carrying body
tissues and ﬂuids of infected piglets [129] and with faecally
shed HEV that contaminates the vicinity of pig production
facilities [129–131] probably contributes to the risk. Hepati-
tis E in people who are occupationally proximate to pigs has
been reported [58,132–135].
Renou et al. [136] described hepatitis E in a person shortly
after being presented a pig, and provided HEV sequencing
data to suggest pet-to-owner transmission. In the III N-
HANES HEV study, the keeping of pets was identiﬁed as
being signiﬁcantly associated with anti-HEV-seroreactivity,
but the OR was not high [37]. The case–control study of
hepatitis E in Germany [25] also enquired into pet exposure,
but found an inverse association. Pet ownership as a substan-
tive link to HEV infection remains difﬁcult to conﬁrm.
Foodborne, Non-zoonotic Transmission
In Italy, England and France, hepatitis E has been ascribed to
shellﬁsh consumption, based primarily on dietary questioning
of case-patients [138–141]. A 2008 outbreak of jaundice on
board a cruise ship, during which 33 passengers were identi-
ﬁed as being HEV-infected, provided the opportunity for a
case–control study to evaluate dietary exposure: eating shell-
ﬁsh was identiﬁed as the most signiﬁcant risk factor [142].
Bivalve molluscs such as clams, mussels, cockles and oys-
ters, which grow in shallow coastal and estuarine waters (envi-
ronments that are prone to sewage pollution), are known
transmitters of enterically transmitted viruses [2,143]. When
they ﬁlter seawater to obtain nutrients, viruses accumulate in
their tissues, so their ingestion is a means whereby a concen-
trated inoculum of virus can be orally delivered to a host,
especially if they are eaten raw. The tendency for molluscs to
be eaten with other shellﬁsh and seafood complicates attribu-
tion of risk speciﬁcally to their consumption [142].
Environmental Transmission
The role of the environment in facilitating the spread of
enterically shed HEV in hyperendemic countries is well rec-
ognized [3,5,144]. In countries with good sanitation facilities,
the extent to which the environment—particularly an urban
one—contributes to the maintenance of HEV endemicity is
less clear. A report of a French engineer who acquired hepa-
titis E following intense exposure to waste-water sludge
[145] is consistent with, but does not prove, environmental
transmission of HEV. Nonetheless, studies conducted in
Spain and The Netherlands revealed that HEV genomic
sequences that cluster with sequences from indigenous hepa-
titis E cases and pigs are recoverable from urban sewage,
waste water and river water [57,146,147]. Such data suggest
the possibility of transmission from: direct contact with sew-
age or sewage sludge; drinking from or being in oral contact
with water contaminated by waste water and sludge efﬂu-
ents; and consumption of food irrigated with water receiving
sewage discharges. The extent of environmental contamina-
tion and the speciﬁc circumstances of exposure [126–
131,145] would inﬂuence the size of the inoculum delivered.
Conclusions
The epidemiology of HEV infection and hepatitis E in hype-
rendemic regions differs signiﬁcantly from that in endemic
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countries. In the former, HEV transmission is primarily
anthroponotic. In the latter, evidence has conﬁrmed that it is
zoonotic: pigs, boars and deer are the reservoirs, and their
meat and offal the vehicles. The extent to which these vehi-
cles effect HEV transmission depends in part on the level of
viral replication in the ﬂesh and entrails of the infected ani-
mals at the time of their slaughter, and on how they are
then processed for eventual human ingestion. Another vari-
ety of food—shellﬁsh—potentially acts as a vehicle of trans-
mission, but of HEV that originates from both humans and
animals. Expedients to preventing meat, offal and shellﬁsh
from conveying HEV along the foodborne route are to avoid
eating them, or—as HEV is relatively resistant to heat
[148,149]—to ensure that they are thoroughly cooked
before being eaten. Nonetheless, human epicurean vagaries
impinge strongly on the adequacy with which the vehicles
are cooked, if at all.
In both hyperendemic and endemic settings, constant pol-
lution of the environment from the active, enteric shedding
of HEV by humans [32,33,39–44,144] and by live animals
[78,79,90,100,121–124,129–131] potentiates further viral
spread. The risk posed is ongoing. Vegans and vegetarians
[1] might not be completely averse to HEV infection and
becoming sick from it.
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